Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Protein Expr Purif ; 49(1): 9-16, 2006 May 06.
Artigo em Inglês | MEDLINE | ID: mdl-16769223

RESUMO

This article has been retracted consistent with Elsevier Policy on Article Withdrawal. Please see . The Publisher apologizes for any inconvenience this may cause.

2.
Artigo em Inglês | MEDLINE | ID: mdl-16709154

RESUMO

The paper entitled "Constitutive expression and characterization of Hepatitis B surface antigen purified by metal affinity precipitation", which was published online on 19 May 2006, was withdrawn at the author's request.

3.
Protein Expr Purif ; 45(1): 206-15, 2006 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16181789

RESUMO

Methicillin-resistant Staphylococcus aureus is a major problem in the world, causing hospital acquired infections and the infections/pathogenesis in community. Lysostaphin is a novel therapeutic molecule to kill the multidrug-resistant S. aureus. Mature lysostaphin is a single polypeptide (approximately 27 kDa) chain metalloprotease glycylglycine endopeptidase, capable of specifically hydrolyzing penta-glycine crosslinks present in the peptidoglycan of the S. aureus cell wall. The mature lysostaphin gene of Staphylococcus simulans has been cloned and overexpressed in the cytoplasm of E. coli with amino terminal hexa-histidine as a fusion partner under the transcriptional control of bacteriophage T7 phi 10 promoter/lac operator and ribosome binding site. The transformed E. coli BL21 (lambdaDE3) cells produced catalytically active soluble (His)6-lysostaphin fusion protein in the cytoplasm representing approximately 20% of the total cellular proteins. The fusion protein was purified to homogeneity using a single chromatographic step of IMAC on Ni-NTA agarose. The present cloning, expression, and purification procedure of recombinant lysostaphin from a non-pathogenic organism E. coli enables preparation of large quantity of r-lysostaphin for structure function studies and evaluation of its clinical potential in therapy and prophylaxis of staphylococcal infections.


Assuntos
Citoplasma/metabolismo , Escherichia coli/genética , Histidina/química , Lisostafina/química , Lisostafina/metabolismo , Staphylococcus/enzimologia , Sequência de Aminoácidos , Catálise , Clonagem Molecular , Ativação Enzimática , Escherichia coli/metabolismo , Regulação Enzimológica da Expressão Gênica , Histidina/genética , Concentração de Íons de Hidrogênio , Lisostafina/isolamento & purificação , Dados de Sequência Molecular , Peso Molecular , Filogenia , Proteínas Recombinantes de Fusão/química , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/isolamento & purificação , Solubilidade , Staphylococcus/classificação , Staphylococcus/genética , Relação Estrutura-Atividade , Temperatura , Fatores de Tempo
4.
Protein Expr Purif ; 41(2): 363-72, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15866723

RESUMO

A hypothetical open reading frame from Bacillus subtilis genome, yjbI [NCBI genome database Accession No. ] having homology to many globin and globin-like proteins from different microbial genomes, was selectively amplified from the chromosomal DNA of B. subtilis strain DB104 based on genome sequence database of B. subtilis strain 168. The gene was cloned and over-expressed in Escherichia coli under the transcriptional control of tandem lambda P(L) and P(R) promoters, and the protein was purified to homogeneity. The single-chain monomeric hemoglobin-like protein is stable to the extent of 5.45 kcal/mol at 25 degrees C, binds carbon mono-oxide, and shows optical spectra characteristic of hemoproteins. The protein also exhibits peroxidase-like activity. This is the first report of a truncated bacterial globin endowed with peroxidase-like activity. The activity is enhanced in the presence of urea and guanidine hydrochloride, more so in the presence of the latter. Presumably, only a small portion of the protein is involved in peroxidase activity, which is exposed with increasing concentration of the denaturants.


Assuntos
Bacillus subtilis/genética , Proteínas de Bactérias/genética , Hemoglobinas/genética , Peroxidases/genética , Sequência de Aminoácidos , Bacillus subtilis/química , Proteínas de Bactérias/química , Proteínas de Bactérias/isolamento & purificação , Clonagem Molecular , Estabilidade Enzimática , Escherichia coli/genética , Regulação Bacteriana da Expressão Gênica , Hemoglobinas/química , Hemoglobinas/isolamento & purificação , Dados de Sequência Molecular , Peso Molecular , Peroxidases/química , Peroxidases/isolamento & purificação , Filogenia , Conformação Proteica , Dobramento de Proteína , Alinhamento de Sequência , Homologia de Sequência de Aminoácidos , Hemoglobinas Truncadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...